{
    "rcn": "199756",
    "acronym": "ChiLTERN",
    "topics": "PHC-18-2015",
    "title": "Childrenís Liver Tumour European Research Network",
    "startDate": "01/01/2016",
    "endDate": "31/12/2020",
    "objective": "Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in the childhood population is hepatoblastoma (HB), usually seen in young children and infants. Much rarer (about 10% of paediatric liver cancers) is hepatocellular carcinoma (HCC), usually seen in the teenage population and sometimes associated with underlying cirrhotic liver diseases. The ChiLTERN project relates to topic PHC 18 ëestablishing effectiveness of health care interventions in the paediatric populationí. The ChiLTERN project builds on a unique opportunity to undertake a comprehensive research programme linked to an ambitious global partnership which will see the single largest clinical trial (the Paediatric Hepatic International Tumour Trial - PHITT) ever undertaken in this population of patients, with several randomised questions in six subgroups of patients. ChiLTERN will allow us to move towards an era of personalised therapy in which each patient will receive the correct amount of chemotherapy and will undergo has the best surgical operation (surgical resection or liver transplant). By using both clinical and biological information, we can assign patients more accurately to risk groups based on their survival. Using genetic tests and biomarkers, we will determine those children who may be at risk of developing long term side effects (deafness, heart failure, kidney damage). In addition, biomarkers will allow us to monitor during therapy and detect toxicities early before serious damage is done so that we can adapt treatment and prevent these problems. Finally, we will be using imaging technology tools which will help our surgeons plan liver operations more safely and effectively. Ultimately ChiLTERN will allow us to cure more children with liver cancer, expose fewer children to toxic chemotherapy and ensure their surgery is both effective and safe.",
    "totalCost": "8191665",
    "ecMaxContribution": "7941665",
    "coordinator": "THE UNIVERSITY OF BIRMINGHAM",
    "coordinatorCountry": "UK",
    "participants": "OUR LADYS CHILDRENS HOSPITAL CRUMLIN;CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES;LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN;SCHWEIZERISCHE PADIATRISCHE ONKOLOGIE GRUPPE (SPOG);UNIVERSITAETSKLINIKUM BONN;OSLO UNIVERSITETSSYKEHUS HF;UNIVERSITY OF NEWCASTLE UPON TYNE;CLINIQUES UNIVERSITAIRES SAINT-LUC;CHRISTIAN-ALBRECHTS-UNIVERSITAET  ZU KIEL;GDANSKI UNIWERSYTET MEDYCZNY;UNIVERSITA DEGLI STUDI DI PADOVA;FAKULTNI NEMOCNICE V MOTOLE;INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL;XenTech SAS;VASTRA GOTALANDS LANS LANDSTING;AZIENDA OSPEDALIERA DI PADOVA;SERVICIO ANDALUZ DE SALUD;EBERHARD KARLS UNIVERSITAET TUEBINGEN;CINECA CONSORZIO INTERUNIVERSITARIO",
    "participantCountries": "IE;FR;DE;CH;NO;UK;BE;PL;IT;CZ;ES;SE",
    "projectParticipants": {
        "928498939": {
            "orgId": "928498939",
            "orgName": "OUR LADYS CHILDRENS HOSPITAL CRUMLIN",
            "ecContrib": 82012
        },
        "998753226": {
            "orgId": "998753226",
            "orgName": "CLINIQUES UNIVERSITAIRES SAINT-LUC",
            "ecContrib": 220552
        },
        "999839529": {
            "orgId": "999839529",
            "orgName": "CHRISTIAN-ALBRECHTS-UNIVERSITAET  ZU KIEL",
            "ecContrib": 105625
        },
        "999995602": {
            "orgId": "999995602",
            "orgName": "UNIVERSITA DEGLI STUDI DI PADOVA",
            "ecContrib": 105625
        },
        "999907526": {
            "orgId": "999907526",
            "orgName": "THE UNIVERSITY OF BIRMINGHAM",
            "ecContrib": 3449971
        },
        "998853621": {
            "orgId": "998853621",
            "orgName": "SERVICIO ANDALUZ DE SALUD",
            "ecContrib": 162125
        },
        "934887650": {
            "orgId": "934887650",
            "orgName": "SCHWEIZERISCHE PADIATRISCHE ONKOLOGIE GRUPPE (SPOG)",
            "ecContrib": 0
        },
        "999523115": {
            "orgId": "999523115",
            "orgName": "INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL",
            "ecContrib": 964206
        },
        "991104000": {
            "orgId": "991104000",
            "orgName": "OSLO UNIVERSITETSSYKEHUS HF",
            "ecContrib": 97938
        },
        "999867465": {
            "orgId": "999867465",
            "orgName": "UNIVERSITAETSKLINIKUM BONN",
            "ecContrib": 224250
        },
        "999651640": {
            "orgId": "999651640",
            "orgName": "VASTRA GOTALANDS LANS LANDSTING",
            "ecContrib": 104375
        },
        "999978433": {
            "orgId": "999978433",
            "orgName": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
            "ecContrib": 659750
        },
        "964458391": {
            "orgId": "964458391",
            "orgName": "FAKULTNI NEMOCNICE V MOTOLE",
            "ecContrib": 24875
        },
        "988378009": {
            "orgId": "988378009",
            "orgName": "CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES",
            "ecContrib": 443706
        },
        "999880754": {
            "orgId": "999880754",
            "orgName": "GDANSKI UNIWERSYTET MEDYCZNY",
            "ecContrib": 158375
        },
        "999991916": {
            "orgId": "999991916",
            "orgName": "EBERHARD KARLS UNIVERSITAET TUEBINGEN",
            "ecContrib": 468750
        },
        "999985417": {
            "orgId": "999985417",
            "orgName": "UNIVERSITY OF NEWCASTLE UPON TYNE",
            "ecContrib": 88905
        },
        "999843409": {
            "orgId": "999843409",
            "orgName": "CINECA CONSORZIO INTERUNIVERSITARIO",
            "ecContrib": 275000
        },
        "999891327": {
            "orgId": "999891327",
            "orgName": "AZIENDA OSPEDALIERA DI PADOVA",
            "ecContrib": 155625
        }
    },
    "calculatedTotalContribution": 7791665
}